People are selling because they are often new to a company like this or this company, and usually they are traders and they want fast money, and they are not likely able to wait it out. Most traders prefer to think they can time everything. That’s kind of the basis of their entire investment premise. <br /> <br /> Many of those trading in the markets right now are pursuing absurd meme stocks. It is basically investing with just the premise that if I am not the last tiger in and such and such a stock is promoted heavily in social media, despite having no premise for creating new value, I will get rich. Many investors right now are pursuing THAT. This is an OTC, small bio, high risk. It is what it is. <br /> <br /> As for a company and product analogy, look again at the 2018 ASCO presentation. The “customers” were thrilled by their treatment and clearly they were handled quite nicely. The regulatory process is not a product. It has many stakeholders, not just the company, but doctors, regulatory agencies, third-party managers, and we are coming out of an unprecedented in modern times, traumatic pandemic.